Cargando…
Increased occurrence of status epilepticus in patients with brain metastases and checkpoint inhibition
Integration of immune checkpoint inhibitors (ICIs) has improved the efficacy of treatment regimens for various cancers. The array of potential side effects keeps evolving and includes neurological complications. An increased risk of seizures and status epilepticus (SE) has been discussed and appears...
Autores principales: | Urban, Hans, Willems, Laurent M., Ronellenfitsch, Michael W., Rosenow, Felix, Steinbach, Joachim P., Strzelczyk, Adam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714514/ https://www.ncbi.nlm.nih.gov/pubmed/33299662 http://dx.doi.org/10.1080/2162402X.2020.1851517 |
Ejemplares similares
-
Clinical characteristics and outcomes of patients with recurrent status epilepticus episodes
por: Bauer, Kristina, et al.
Publicado: (2023) -
High end-of-life incidence of seizures and status epilepticus in patients with primary and secondary brain tumors
por: Brauchitsch, Sophie von, et al.
Publicado: (2022) -
Trends and Differences in Status Epilepticus Treatment of Children and Adults Over 10 Years: A Comparative Study of Medical Records (2012–2021) from a University Hospital in Germany
por: Purwien, Leonore, et al.
Publicado: (2023) -
Therapeutic Options for Patients with Refractory Status Epilepticus in Palliative Settings or with a Limitation of Life-Sustaining Therapies: A Systematic Review
por: Willems, Laurent M., et al.
Publicado: (2020) -
Correction to: Therapeutic Options for Patients with Refractory Status Epilepticus in Palliative Settings or with a Limitation of Life‑Sustaining Therapies: A Systematic Review
por: Willems, Laurent M., et al.
Publicado: (2021)